1-8 of 8
metastatic neoplasm, central nervous system
Close
Sort by
Journal Articles

PI3Kα/δ Inhibitor, Copanlisib, Inhibits Acute Lymphoblastic Leukemia Cell Growth, Increases Survival and Inhibits CNS Disease Progression in Leukemic Mice

Sarah Ridge, PhD, Hisayuki Yao, PhD, Trevor T Price, PhD, Andrew E Whiteley, PhD, Maegan Burns, Dorothy A. Sipkins, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2758.
https://doi.org/10.1182/blood-2019-132097
Published: 2019
Journal Articles

Acute Lymphoblastic Leukemia Cells Bypass the Blood Brain Barrier to Enter the CNS Via a Neuronal Developmental Pathway

Hisayuki Yao, MD PhD, Matthew Warner, PhD, Trevor Price, PhD, Lindsey Olivere, Gaia Cantelli, PhD, Sarah Ridge, PhD, Brandon Ngo, Surya Ravichandran, Stacey Tannheimer, PhD, Anjen Chenn, MD PhD, Dorothy A. Sipkins, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 144.
https://doi.org/10.1182/blood.V130.Suppl_1.144.144
Published: 2017
Journal Articles

Expression of B and T Lymphocyte Attenuator (BTLA) Correlates with CNS Metastasis and Adverse Prognosis in Activated B-Cell Lymphoma and Acute Lymphoblastic Leukemia

Huimin Geng, PhD, Zhengshan Chen, PhD, Shawn Anderson, Eleanor Fraser, PhD, Ming Lu, Chen Lingjing, PhD, Colin Collins, PhD, Muschen Markus, PhD, James L. Rubenstein, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3900.
https://doi.org/10.1182/blood.V126.23.3900.3900
Published: 2015
Journal Articles

Risk of Intracranial Hemorrhage Associated with Enoxaparin Administration in Patients with Brain Metastasis

Jessica Donato, MD, Federico Campigotto, MS, Erika Coletti, BSN, Donna Neuberg, ScD, Griffin Weber, MD PhD, Jeffrey I. Zwicker, MD
Journal: Blood
Blood (2014) 124 (21): 348.
https://doi.org/10.1182/blood.V124.21.348.348
Published: 2014
Journal Articles

An Internet-Based Registry For The Documentation Of Neoplastic Meningitis

Herwig Strik, Hans Rock
Journal: Blood
Blood (2013) 122 (21): 5617.
https://doi.org/10.1182/blood.V122.21.5617.5617
Published: 2013
Journal Articles

A Phase I/II Study of Escalating Doses of Thalidomide (Thal) in Conjunction with Bortezomib (Vel) and High Dose Melphalan (Mel) As A Conditioning Regimen for Autologous Peripheral Blood Stem Cell Transplantation (PBSCT) in Patients with Advanced Multiple Myeloma (MM).

Sung H Hong, David S Siegel, MD, PhD., Michele L Donato, MD, David H. Vesole, MD, PhD, Andrew L Pecora, MD, Joshua R. Richter, MD, Emily Brown, BSN, RN, CHPN, Kathryn Buttner, BSN, RN, OCN, Marie DelFavero, BSN, RN, CCRP, Daniel Kim, Andrea Ortega, BA, CCRP, Scott D Rowley, MD
Journal: Blood
Blood (2012) 120 (21): 3104.
https://doi.org/10.1182/blood.V120.21.3104.3104
Published: 2012
Journal Articles

Genomic and Molecular Properties of Relapsed CNS Lymphoma Using Novel Primary Meningeal Lymphoma Cell Lines and Intracranial Xenografts,

Hua-Xin Gao, Ph.D., Shawn Anderson, Lingjing Chen, Ph.D., Cigall Kadoch, BA, Byron C Hann, MD, PhD, Clifford Lowell, MD, PhD, Colin Collins, Ph.D., James L. Rubenstein, M.D., Ph.D.
Journal: Blood
Blood (2011) 118 (21): 3477.
https://doi.org/10.1182/blood.V118.21.3477.3477
Published: 2011
Journal Articles

Phase 2 Study of Talabostat and Rituximab in Patients with Advanced Chronic Lymphoctyic Leukemia (CLL) Previously Treated with a Rituximab/Fludarabine Regimen.

Khuda D. Khan, MD, PhD, Susan O’Brien, MD, Kanti R. Rai, MD, Jennifer R. Brown, MD, PhD, Perry Cook, MD, Anne Marie Maddox, MD, Alison M. Duarte, MPH, Eric J. Haltom, Margaret J. Uprichard, PharmD
Journal: Blood
Blood (2005) 106 (11): 2125.
https://doi.org/10.1182/blood.V106.11.2125.2125
Published: 2005